202 related articles for article (PubMed ID: 33615655)
1. The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities.
Varela-Calviño R; Rodríguez-Quiroga M; Dias Carvalho P; Martins F; Serra-Roma A; Vázquez-Iglesias L; Páez de la Cadena M; Velho S; Cordero OJ
IUBMB Life; 2021 May; 73(5):761-773. PubMed ID: 33615655
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl Peptidase-4 Stabilizes Integrin α4β1 Complex to Promote Thyroid Cancer Cell Metastasis by Activating Transforming Growth Factor-Beta Signaling Pathway.
He Q; Cao H; Zhao Y; Chen P; Wang N; Li W; Cui R; Hou P; Zhang X; Ji M
Thyroid; 2022 Nov; 32(11):1411-1422. PubMed ID: 36166219
[No Abstract] [Full Text] [Related]
3. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
Nishina S; Yamauchi A; Kawaguchi T; Kaku K; Goto M; Sasaki K; Hara Y; Tomiyama Y; Kuribayashi F; Torimura T; Hino K
Cell Mol Gastroenterol Hepatol; 2019; 7(1):115-134. PubMed ID: 30510994
[TBL] [Abstract][Full Text] [Related]
4. DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice.
Kawasaki T; Chen W; Htwe YM; Tatsumi K; Dudek SM
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L834-L845. PubMed ID: 30188745
[TBL] [Abstract][Full Text] [Related]
5. Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro.
Pinheiro MM; Stoppa CL; Valduga CJ; Okuyama CE; Gorjão R; Pereira RM; Diniz SN
Eur J Pharm Sci; 2017 Mar; 100():17-24. PubMed ID: 28065853
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.
Lee JJ; Wang TY; Liu CL; Chien MN; Chen MJ; Hsu YC; Leung CH; Cheng SP
J Clin Endocrinol Metab; 2017 Aug; 102(8):2930-2940. PubMed ID: 28575350
[TBL] [Abstract][Full Text] [Related]
7. Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells.
Beckenkamp A; Willig JB; Santana DB; Nascimento J; Paccez JD; Zerbini LF; Bruno AN; Pilger DA; Wink MR; Buffon A
PLoS One; 2015; 10(7):e0134305. PubMed ID: 26222679
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth.
Hollande C; Boussier J; Ziai J; Nozawa T; Bondet V; Phung W; Lu B; Duffy D; Paradis V; Mallet V; Eberl G; Sandoval W; Schartner JM; Pol S; Barreira da Silva R; Albert ML
Nat Immunol; 2019 Mar; 20(3):257-264. PubMed ID: 30778250
[TBL] [Abstract][Full Text] [Related]
9. DPP-4 (CD26) inhibitor sitagliptin exerts anti-inflammatory effects on rat insulinoma (RINm) cells via suppressing NF-κB activation.
Hu X; Liu S; Liu X; Zhang J; Liang Y; Li Y
Endocrine; 2017 Mar; 55(3):754-763. PubMed ID: 27612849
[TBL] [Abstract][Full Text] [Related]
10. Targeting cluster of differentiation 26 / dipeptidyl peptidase 4 (CD26/DPP4) in organ fibrosis.
Ohm B; Moneke I; Jungraithmayr W
Br J Pharmacol; 2023 Nov; 180(22):2846-2861. PubMed ID: 36196001
[TBL] [Abstract][Full Text] [Related]
11. Effects of dipeptidyl peptidase-4 inhibitors on transforming growth factor-β1 signal transduction pathways in the ovarian fibrosis of polycystic ovary syndrome rats.
Wang F; Zhang ZF; He YR; Wu HY; Wei SS
J Obstet Gynaecol Res; 2019 Mar; 45(3):600-608. PubMed ID: 30515927
[TBL] [Abstract][Full Text] [Related]
12. The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity.
Jang JH; Janker F; De Meester I; Arni S; Borgeaud N; Yamada Y; Gil Bazo I; Weder W; Jungraithmayr W
Carcinogenesis; 2019 Apr; 40(2):324-334. PubMed ID: 30698677
[TBL] [Abstract][Full Text] [Related]
13. Head-to-head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injury.
Reichetzeder C; von Websky K; Tsuprykov O; Mohagheghi Samarin A; Falke LG; Dwi Putra SE; Hasan AA; Antonenko V; Curato C; Rippmann J; Klein T; Hocher B
Br J Pharmacol; 2017 Jul; 174(14):2273-2286. PubMed ID: 28423178
[TBL] [Abstract][Full Text] [Related]
14. Effects of linagliptin on human immortalized podocytes: a cellular system to study dipeptidyl-peptidase 4 inhibition.
Miglio G; Vitarelli G; Klein T; Benetti E
Br J Pharmacol; 2017 May; 174(9):809-821. PubMed ID: 28177527
[TBL] [Abstract][Full Text] [Related]
15. Modelling the sitagliptin effect on dipeptidyl peptidase-4 activity in adults with haematological malignancies after umbilical cord blood haematopoietic cell transplantation.
Vélez de Mendizábal N; Strother RM; Farag SS; Broxmeyer HE; Messina-Graham S; Chitnis SD; Bies RR
Clin Pharmacokinet; 2014 Mar; 53(3):247-259. PubMed ID: 24142388
[TBL] [Abstract][Full Text] [Related]
16. Urinary DPP4 correlates with renal dysfunction, and DPP4 inhibition protects against the reduction in megalin and podocin expression in experimental CKD.
Benetti A; Martins FL; Sene LB; Shimizu MHM; Seguro AC; Luchi WM; Girardi ACC
Am J Physiol Renal Physiol; 2021 Mar; 320(3):F285-F296. PubMed ID: 33346727
[TBL] [Abstract][Full Text] [Related]
17. Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice.
Jang JH; Baerts L; Waumans Y; De Meester I; Yamada Y; Limani P; Gil-Bazo I; Weder W; Jungraithmayr W
Clin Exp Metastasis; 2015 Oct; 32(7):677-87. PubMed ID: 26233333
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of DPP4 promotes the proliferation and the activation of the CREB/aromatase pathway in ovarian granulosa cells.
Lin L; Wang L
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 35014677
[TBL] [Abstract][Full Text] [Related]
19. Sitagliptin ameliorates renal tubular injury in diabetic kidney disease via STAT3-dependent mitochondrial homeostasis through SDF-1α/CXCR4 pathway.
Zhang Q; He L; Dong Y; Fei Y; Wen J; Li X; Guan J; Liu F; Zhou T; Li Z; Fan Y; Wang N
FASEB J; 2020 Jun; 34(6):7500-7519. PubMed ID: 32281218
[TBL] [Abstract][Full Text] [Related]
20. Development of a
Yazbeck R; Jaenisch S; Squire M; Abbott CA; Parkinson-Lawrence E; Brooks DA; Butler RN
Sci Rep; 2019 Mar; 9(1):4906. PubMed ID: 30894647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]